Neutrophil/HDL-C, Lymphocyte/HDL-C and Monocyte/HDL-C in subjects with asymptomatic carotid atherosclerosis

被引:0
|
作者
Caimi, Gregorio [1 ]
Lo Presti, Rosalia [2 ]
Urso, Caterina [3 ]
Brucculeri, Salvatore [3 ]
Carlisi, Melania [1 ]
机构
[1] Univ Palermo, Dept Hlth Promot Mother & Child Care, Internal Med & Med Specialties, Palermo, Italy
[2] Univ Palermo, Dept Psychol Educ Sci & Human Movement, Palermo, Italy
[3] Fdn Ist G Giglio Cefalu, Emergency Unit, Palermo, Italy
关键词
Leukocyte count; neutrophils; lymphocytes; monocytes; HDL-Cholesterol; DIFFERENTIAL LEUKOCYTE COUNTS; LONG-TERM MORTALITY; METABOLIC SYNDROME; RATIO; RISK; REVASCULARIZATION; PREDICTORS; DISEASE; EVENTS;
D O I
10.3233/CH-232019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Leukocyte count is a prognostic marker for cardiovascular diseases, with key role in atherosclerosis development. Specific number of neutrophils, lymphocytes and monocytes can predict cardiovascular risk, also in asymptomatic subjects. Among the lipoprotein fractions, HDL-C is a protective factor in the cardiovascular disorders. For the above reason, we have examined the peripheral count of leukocytes, neutrophils, lymphocytes and monocytes, and the ratios between neutrophils/HDL-cholesterol, lymphocytes/HDL-cholesterol, and monocytes/HDL-cholesterol, to evaluate the possible utility of the obtained values in progression of asymptomatic carotid atherosclerosis. METHODS: We performed our analysis in a cohort of 100 subjects with asymptomatic carotid atherosclerosis, of which 43 men and 57 women. The data were expressed as medians and IQR. To analyse the differences in leukocyte, neutrophil, lymphocyte, monocytes count and their ratio with HDL-cholesterol the Mann-Whitney test was employed. RESULTS: The peripheral count of leukocyte subtypes and the ratios, they change in relation to the number of cardiovascular risk factors and the degree of insulin resistance. CONCLUSIONS: In this cohort of subjects, the percentage of observed cardiovascular risk factors significantly affect some leukocyte parameters. These results allow us to underline the importance of the leukocyte indices in the evaluation of subjects with asymptomatic vascular atherosclerosis.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [41] LDL-C/HDL-C Ratio Predicts Carotid Intima-Media Thickness Progression Better Than HDL-C or LDL-C Alone
    Enomoto, Mika
    Adachi, Hisashi
    Hirai, Yuji
    Fukami, Ako
    Satoh, Akira
    Otsuka, Maki
    Kumagae, Shun-Ichi
    Nanjo, Yasuki
    Yoshikawa, Kuniko
    Esaki, Eishi
    Kumagai, Eita
    Ogata, Kinuka
    Kasahara, Akiko
    Tsukagawa, Eri
    Yokoi, Kanako
    Ohbu-Murayama, Kyoko
    Imaizumi, Tsutomu
    JOURNAL OF LIPIDS, 2011, 2011
  • [42] Serum HDL-C levels, log (TG/HDL-C) values and serum total cholesterol/HDL-C ratios significantly correlate with radiological extent of disease in patients with community-acquired pneumonia
    Deniz, O
    Tozkoparan, E
    Yaman, H
    Cakir, E
    Gumus, S
    Ozcan, O
    Bozlar, U
    Bilgi, C
    Bilgic, H
    Ekiz, K
    CLINICAL BIOCHEMISTRY, 2006, 39 (03) : 287 - 292
  • [43] PPARα agonists, HDL-C and the metabolic syndrome
    Fruchart, JC
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 10 - 10
  • [44] 缺血性脑卒中患者TC/HDL-C、TG/HDL-C比值与HDL亚类分布的关系
    韩瑛
    陈志军
    卢新华
    邓华菲
    王岐本
    孙陶利
    龙石银
    田英
    湘南学院学报(医学版), 2014, 16 (02) : 1 - 4
  • [45] Phosphatidylinositol increases HDL-C levels in humans
    Burgess, JW
    Neville, TAM
    Rouillard, P
    Harder, Z
    Beanlands, DS
    Sparks, DL
    JOURNAL OF LIPID RESEARCH, 2005, 46 (02) : 350 - 355
  • [46] METABOLIC DETERMINANTS OF LOW HDL-C LEVELS
    BRESLOW, JL
    EISENBERG, S
    BRINTON, EA
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 676 : 157 - 162
  • [47] THE FORMULA OF APO A FROM HDL-C AND TG
    Omi, T.
    ATHEROSCLEROSIS, 2020, 315 : E157 - E157
  • [48] ANTIPYRINE CLEARANCE, HDL-C AND TRAINING STATUS
    FARRELL, PA
    GUSTAFSON, AB
    BARBORIAK, JJ
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1983, 15 (02): : 184 - 184
  • [49] The CETP genotype and HDL-C in FH patients
    Zwart, M
    Smilde, TJ
    Stalenhoef, AFH
    Prins, MH
    Trip, MD
    Kastelein, JJP
    Molhuizen, HO
    CIRCULATION, 1999, 100 (18) : 818 - 818
  • [50] Intervening on HDL-C: Is it possible? Does it work?
    Wierzbicki, A. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (11) : 1782 - 1786